Shandong Yinfeng Life Sciences Research Institute completed China’s first human body cryopreservation
Release time:
2017-08-13
In most people's minds, human cryopreservation is both mysterious and unfamiliar. In 2015, news that a female writer from Chongqing had her brain frozen at the Alcor Life Extension Foundation (Alcor) in the United States attracted great attention. This was also the first case of cryopreservation of human brains in China. Now, it is funded by the Shandong Yinfeng Life Science Charity Foundation. China's first whole-body cryopreservation surgery funded by the Society was successfully completed by Shandong Yinfeng Life Sciences Research Institute, marking China becoming the third country in the world to achieve human cryopreservation after the United States and Russia.
Staff pay tribute to volunteers who participated in China's first human cryopreservation case
On August 13, after being invited by some media such as Science and Technology Daily, China News Network, Ifeng.com and Red Star News, China's first human cryopreservation media meeting was held at Yinfeng Biological Group, the sponsor of the Yinfeng Life Science Charity Foundation in Shandong Province. More than a dozen mainstream media in Shandong Province, including Dazhong.com, Life Daily, Qilu Evening News, Jinan Times, Xinhuanet, Yidian News, Toutiao, China Shandong Net, Luwang, Sina Shandong, Phoenix Net, etc., took the initiative to participate in the meeting. Yinfeng Biotech Group Chairman Sheng Dewei, Acting President Pang Yong, and medical experts involved in this cryopreservation surgery: Sun Wenyu, Director of the Cardiac Surgery Department of Qilu Hospital of Shandong University, Lei Weifu, an anesthesia expert and director of the comfort ward, Clinical Response of Shandong Yinfeng Life Sciences Research Institute Expert Aaron Drake attended the meeting.
Human cryopreservation refers to preserving the human body in a low-temperature environment of more than minus 190 degrees Celsius, in anticipation of future technological development and the realization of "resurrection from the dead." At the media conference, Aaron Drake said: Some people think that although today’s medical technology cannot cure their terminal illnesses, relying on current preservation technology to preserve the body, perhaps in the future medical technology will develop to a certain extent. Degree can be cured. For example, 100 years ago, if someone suffered heart damage, we could only watch him die; but today, people can recover through surgery after a heart attack. So we can also imagine that cancer will be cured in the future. The cryopreservation of human bodies has become a way for people to wait until a cure for cancer appears.
It is understood that the person who applied for cryopreservation of human body was a 49-year-old woman named Zhan who suffered from lung cancer. During her lifetime, she was a charity-loving and caring volunteer in Quancheng. She expressed her wish to donate her body for scientific research to her family many times. During her treatment in the comfort ward, her family completed the body donation registration procedures on her behalf and participated in this great and loving life extension research plan: cryogenically preserving herself in the hope of miracles in future medical technology. At 4:01 a.m. on May 8, 2017, the 49-year-old Ms. Zhan stopped her heartbeat and breathing in the hospital bed, and the cryopreservation surgery officially began. On the evening of May 10, Ms. Zhan’s body was successfully transferred to a special liquid nitrogen container filled with liquid nitrogen that could be stably maintained at minus 196°C, and the operation was successfully completed. The completion of this operation is not only the realization of her wish to dedicate great love, but also leaves a hope for her family.
Since its establishment with the approval of the Shandong Provincial Department of Civil Affairs, the Shandong Yinfeng Life Sciences Charity Foundation has long-term funded the Shandong Yinfeng Life Sciences Research Institute to carry out research in the field of cryogenic medicine such as cryopreservation, resuscitation and organ function maintenance of various tissues, organs and human bodies. It has established a team of experts including international cryogenic biology experts, cryogenic medicine and clinical medicine, and has successfully achieved cryopreservation, recovery and clinical application of a variety of human cells, including valves, skin, severed fingers (toes) and ovarian tissue. We have also achieved breakthrough research results in the cryopreservation and recovery of individual large-sized organs. At the same time, it has funded expert teams to conduct inspections and exchanges at human cryopreservation research institutions such as the Alcor Life Extension Foundation (Alcor), the Human Preservation Institute (CI) in the United States, and KrioRus in Russia, combining the current domestic and foreign cryogenic surgery, cryogenic medicine The latest technology and years of cell tissue preservation experience, as well as repeated demonstrations and multiple experiments by a team of clinical experts and cryogenic medicine experts, have led to the formulation of a technical plan for human cryopreservation research over several years.
The successful completion of this human cryopreservation surgery is a breakthrough in biomedical technology. However, for the Shandong Yinfeng Life Sciences Charity Foundation, only by strengthening cooperation with other public welfare organizations and medical institutions and raising more funds to fund research in the field of life sciences can we better ensure the smooth implementation of human cryopreservation. convoy.
Next article
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
